Chemical Insights into Hymenocardia Acida Leaf Extract and Computational Effects of its Constituents on Cyclooxygenases -1 and 2 Activities
Keywords:
citicoline; medical food; acute ischemic stroke; evidence-based medicine; philosophy of science., elemental analysis, compound profiling, cyclooxygenases, Hymenocardia acida, in-silico studiesAbstract
The present study analyzed the chemical constituents of the Methanol leaf extract of Hymenocardia acida (MLEHA), and its In-silico parameters. The MLEHA was obtained by Soxhlet extraction, and then subjected to Atomic Absorption Spectroscopy (AAS), High performance liquid chromatography (HPLC) and Gas Chromatography-Flame ionization detection (GC-FID). The ADME-T and molecular docking studies were performed on orientin and chromone from HPLC and GC-FID data, using rofecoxib and diclofenac as reference drugs. The MLEHA contains high levels of nickel, zinc, cobalt and iron. The HPLC depicts presence of 3- hydroxybenzoic acid, betulinic acid, orientin, beta- sitosterol, coumarin, stigmasterol, rutin, friedelin, chromon, squalene, lupeol and vitexin. whereas CG-FID shows presence of 3- hydroxybenzoic acid, betulinic acid, oleic acid, orientin, coumarin, chromon, paviin, hymenocardine, homopterocarpin, stigmasterol, rutin, friedelin, squalene, vitexin, alpha- colubrin, chelidonin and anthatrone. The ADME-T analysis shows that orientin has the least Caco-2 permeability and highest p- glycoprotein inhibition among the four compounds. Orientin and chromone showed higher induction and lower inhibition potentials on Cytochrome-p450 enzymes relative to rofecoxib and diclofenac. Orientin showed lower carcinogenicity and mutagenicity than rofecoxib and diclofenac. Orientin, chromone, rofecoxib and diclofenac have binding energies of -2.3, -5.6, -5.7 and – 5.6 kcal/mol with COX-1, and -6.10, -7.0, -9.7 and -7.6 kcal/mol with COX-2, respectively. Orientin formed H-bonds with Asn80, His43 and Arg83, while diclofenac formed H-bonds with Gln461, Tyr130 and Cys41 of COX-1 enzyme. Orientin formed H-bonds with Glu524, Ser119(2), Arg120, whereas rofecoxib forms H-bonds with Arg513 and His90 of COX-2 enzyme. This study has shown that Hymenocardia acida leaf is rich in minerals and phytochemicals. Orientin could potentially inhibit Cyclooxygenases- 1 and 2 activities, which are involved in development of pains and inflammation.
References
T. A. Tor-Anyinam, R. Y. Shimbe, J. V. Anyam (2013) Phytochemical and medicinal activities of Hymenocardia acida Tul (Euphorbiaceae): A review. 3, 11-16.
A. A. Ajao, A. A. Alimi, O. A. Olatunji, O. F. Balogun, A. S. Saheed (2017) A synopsis of antipsychotic medicinal plants in Nigeria. https://doi.org/10.1080/0035919X.2017.1386138
M. A. Motaleb (2011) Selected medicinal plants of Chittagong Hills Tract. xii+ 116.
F. Afolabi, O. J. Afolabi (2013) Phytochemical constituents of some medicinal plants in South West, Nigeria. 4(1), 76-78.
A. H. Abu, C. N. Uchendu (2011) Antifertility activity of aqueous ethanolic extract of Hymenocardia acida stem bark in female rats. 9(3), 217-222.
E. Tuenter, V. Exarchou, A. Baldè, P. Cos, L. Maes, S. Apers, L. Pieters (2016) Cyclopeptide alkaloids from Hymenocardia acida. 79(7), 1746-1751.
R. W. J. Keay (1989) Trees of Nigeria. 179-181.
B. N. Bum, G. S. Taiwe, F. C. O. Moto, G. T. Ngoupaye, R. R. N. Vougat, V. D. Sakoue, C. Gwa, E. R. Ayissi, C. Dong, A. Rakotonirina, S. V. Rakotonirina (2011) Antiepileptic medicinal plants used in traditional medicine to treat epilepsy. 175-192.
H. Ibrahim, F. S. Sani, B. H. Danladi, A. A. Ahmadu (2007) Phytochemical and antisickling studies of the leaves of Hymenocardia acida Tul (Euphorbiaceae). 10(5), 788-791s.
I. P. Udeozo, C. M. Ejikeme, A. N. Eboatu, H. I. Kelle (2017) An assay of some thermal characteristics, chemical and phytochemical constituents of Hymenocardia acida Timber. 21(5), 951-935.
M. O. Sofidiya, O. O. Odukoya, A. J. Afolayan, O. B. Familoni (2009) Phenolic contents, antioxidant and antibacterial activities of Hymenocardia acida. 23(2), 168-177.
N. P. Olotu, H. Ibrahim, N. Ilyas, U. Ajima, A. I. Olotu (2011) Phytochemical screening and analgesic studies of the root bark of Hymenocardia acida, Tul (Euphorbiaceae). 3(1), 219-223.
C. M. Starks, R. H. Williams, V. L. Norman, S. M. Rice, M. O'Niel-Johnson, J. M. Lawrence, G. R. Eldridge (2014) Antibacterial Chromone and Chromone stilbenoids from Hymenocradia acida. 98, 216-222.
O Adedokun, E N Ntungwe, C Viegas, B A Ayinde, L Barboni, F Maggi, R Saraiva, P Rijo, P Fonte (2022) Enhanced anticancer activity of Hymenocardia acida stem bark extract loaded into PLGA nanoparticles. 15(5), 535.
D M Skovronsky, V M Y Lee, J Q Trojanowski (2006) Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. 1, 151-170.
E O Oshomoh, M Ndu (2013) Antimicrobial and antifungal activities of ethanol and aqueous cute extracts of Hymenocardia acida stem against selected dental caries pathogens. 4(29), 55-60.
S Koffi, T Y Soro, K E Begbin, G Abizi, M E Ahebe, K J Kouadio, N E Zougrou, K Kouakou (2022) Acute and subchronic toxicities of the aqueous extract of the Hymenocardia acida (Euphorbiaceae) roots in rodents. 33(1), 39-48.
A M Usman, N M Danjuma, J Ya'u, M M Ahmad, Z Alhassan, Y M Abubakar (2021) Antidiarrhoeal potential of methanol extract of Hymenocardia acida Tul (Euphorbiaceae) in laboratory animals. 45(1), 118.
I C Obidike, M S Idris-Usman, L B John-Africa, O A Salawu (2011) An evaluation of acute and subchronic toxicological effects of H. acida leaf extract in adult Wistar rats. 6(4), 400-408.
R M Smith, D I De With, R M Garavito (2000) Cyclooxygenases: structural, cellular and molecular biology. 69, 145-182.
F Burdan, A Chalas, J Szumilo (2006) Cyklooksygenaza i prostanidy- znaczeine bioloczne. 60, 129-141.
J R Vane, R M Botting (2003) The mechanism of action of aspirin. 11(5-6), 255-258.
J R Vane, R M Botting (1998) Mechanism of action of nonsteroidal anti-inflammatory drugs. 104(31), 2S-8S.
J D Kumar, F Zanderigo, J Prabhakan, H Rubin-Falcone, R V Parsey, J J Mann (2018) In vivo evaluation of [11C] TMI, a COX -2 selective PET tracer, in baboons. 28(23-24), 3592-3595.
N Zidar, K Odar, D Glavac, M Jerse, T Zupanc, D Stajer (2009) Cyclooxygenase in normal human tissues- is COX-1 really a constitutive isoform, and COX -2 an inducible isoform?. 13(9b), 3753-3763.
A T Koki, J L Masferrer (2002) Celecoxib: a specific COX-2 inhibitor with anticancer properties. 9(2_suppl), 28-35.
N Kundu, A M Fulton (2002) Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer. 62(8), 2343 - 2346.
J D Veltman, M E Lambers, M van Nimwegen, R W Hendriks, H C Hoogstenden, J G Aerts (2010) COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function. 10(1), 1-13.
C A Lipinski, F Lombardo, B W Dominy, P J Feeney (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. 46(1-3), 3–26.
G E Adeleke, O Q Owolabi, G A Berena, R A Ajani, R O Adeyi, P K Orisadiran, M A Bello, R B Abdulateef, T T Olasinde, K O Oriaje, I A Aransi, K O Elaigwu, O S Shoyinka, M B Awoyemi, M Akano (2023) Chemical characterization of Hymenocardia acida stem bark extract and modulation of selected enzymes in Kidney and Heart of Wistar rats. 11(9), 425-442.
I T Klip, J Comin-Colet, A A Voors (2013) Iron deficiency in chronic heart failure: an international pooled analysis. 575-582 e573.
S D Anker, J Comin-Colet, G Filippatos, R Willenheimer, K Dickstein, H Drexler, T F Luscher, B Bart, W Banasiak, J Niegowska (2009) Ferric carboxymaltose in patients with heart failure and iron deficiency. 361, 2436-2448.
P Ponikowski, D J van Veldhuisen, J Comin-Colet (2015) Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. 36(11), 657-668.
G I Stangl, M Kirchgessner (1996) Nickel deficiency alters liver lipid metabolism in rats. 126, 2466-2473.
J C King, D M Shames, L R Woodhouse (2000) Zinc homeostasis in humans. 130, 1360S-6S.
R J Fessenden, J S Fessenden (1986) Organic chemistry.
R L Shriner, C K F Hermann, T C Morril, D Curtin, R C Fuson (2004) The Systematic identification of organic compounds. 194-227.
K Y Lam, A P K Ling, R Y Koh, Y P Wong, Y H Say (2016) Review on Medicinal Properties of Orientin. 4104595, 1-9.
T Kalaiyarasu, N Karthi, S Kandakumar, P Mariyappan, G Mydhili, S Vanitha, V Manju (2018) Orientin mitigates 1,2-dimethylhydrazine-induced lipid peroxidation, antioxidant and biotransforming bacterial enzyme alteration in experimental rats. 14(6), 1379-1388.
L C F Opretzka, R D F Espirito-Santos, O A Nascimento, L S Abreu, I M Alves, E Doring, M B P Soares, E D S Velozo, S A Laufer, C F Villareal (2019) Natural chromosomes as potential anti-inflammatory agents: Pharmacological properties and related mechanisms. 72, 31-39.
X C Fu, M W Wang, S P Li, Y Zhang, H L Wang (2005) Vasodilation produced by orientin and its mechanism study. 28(1), 37–41.
X C Fu, M W Wang, S P Li, Y Zhang, H L Wang (2006) Anti-apoptotic effect and the mechanism of orientin on ischaemic/reperfused myocardium. 8(3), 265–272.
R B Van Breemen, Y Li (2005) Caco-2 cell permeability assays to measure drug absorption. 1(2), 175-185.
B Press, D Di Grandi (2008) Permeability for intestinal absorption: Caco - 2 assay and related issues. 893 - 900.
L Liu, L Guo, C Zhao, X Wu, R Wang, C Liu (2015) Characterization of the intestinal absorption os seven flavonoids from the flowers of Trollius chinensis using the Caco-2 cell monolayer model. e01119263.
S Jian, Lijun Z, Ye L, Haihui Z, Jia Y, Linlin L, Zhongqiu L (2016) In vitro study of UGT metabolism and permeability of orientin and isoorientin active flavonoid C-glycosides. 10(2), 101-110.
I B Paek, Y Moon, J Kim, H Y Ji, S A Kim, D H Sohn, J B Kim, H S Lee (2006) Pharmacokinetic of a ginseng saponin metabolite compound K in rats. 27, 39 – 45.
Z Yan, J R Wang, T Niu, S Gao, T Yin, M You, Z H Jang, M Hu (2012) Inhibition of P-glycoprotein leads to improved oral bioavailability of compound K, and anticancer metabolite of red ginseg extract produced by rats gut microflora. 40, 1538 – 1544.
I Ahmed, D N Leach, H Wohlmuth, J J De Voss, J T Blanchfield (2020) Caco - 2 permeability of flavonoids and saponins from Gynostemma pentaphyllum: the Immortal Herb. 5(43), 21561- 21569.
LC Pirvu, L Pintilie, A Albulescu, A Stefaniu, G Neagu (2023) Anti-proliferative potential of Cynaroside and Orientin – In silico (DYRK2) and in vitro (U87 and Caco-2) studies. 24(23), 16555.
KO Alfarouk, CM Stock, S Taylors, M Walsh, AK Muddathir, D Verduzco, OY Mohammed, GO Elhassan, S Harguindey, SJ Reshkin, C Rauch (2015) Resistance to cancer chemotherapy: failure in drug response from ADME to P-glycoprotein. 15, 71.
JR Keifer, JL Pawlitz, KT Moreland, RA Stageman, WF Hood, JK Gierse, AM Stevens, DC Goodwin, SW Rowilson, LJ Marnett, WC Stallings, RG Kurumbail (2000) Structural insights into the stereochemistry of the cyclooxygenase reaction. 405, 97-101.
Shaveta A, A Singh, M Kaur, S Sharma, R Bhatti, P Singh (2014) Rational design, synthesis and evaluation of chrome-indole and chromome-pyrazole based conjugates: Identification of a lead for anti-inflammatory drug. 77, 185-192.
S Beura, P Chetti Identification of potential human COX-2 inhibitors using computational modeling and molecular dynamics.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Authors and Global Journals Private Limited
This work is licensed under a Creative Commons Attribution 4.0 International License.
